ARROW Pharmaceuticals has set its sights firmly on the Dose Administration Aid (DAA) market in Australia, announcing the formation of a new joint venture with NZ firm Douglas Pharmaceuticals called MyPak Solutions (PD breaking news).
The JV partners noted that the government had "recognised the important role of DAAs in community health care by providing funding of $100 million in the 2017/18 financial year to enable community pharmacists to provide DAA services".
MyPak Solutions has purchased Practicare and taken over Medico Pak from Arrow, and also holds the Australian distribution rights to the Japanese-made Alpaca Blister Pack Dispensing Robot.
Arrow Pharmaceuticals chairman Dennis Bastas said the combined businesses would enable MyPak Solutions to provide its customers with a "complete solution in the DAA market in Australia".
Douglas Pharmaceuticals md Jeff Douglas said as leaders in the DAA market in New Zealand "we will be bringing our learnings to this joint venture with Arrow for the Australian market".
Arrow Pharmaceuticals acquired the Australian retail pharmacy business of Amneal Pharmaceuticals last year (PD 01 Sep 2017), with the deal including Amneal's Medico Pak dose administration aid operations which are now part of the newly formed joint venture.
The above article was sent to subscribers in Pharmacy Daily's issue from 27 Mar 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Mar 18
